ArticleMultiple sclerosis and related disorders2023

In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab.

Anat Achiron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.